Dakota Wealth Management Lowers Stake in The Clorox Company (NYSE:CLX)

Dakota Wealth Management trimmed its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 13.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 11,896 shares of the company's stock after selling 1,843 shares during the quarter. Dakota Wealth Management's holdings in Clorox were worth $1,932,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Brooklyn Investment Group lifted its stake in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Clorox during the third quarter worth $27,000. Continuum Advisory LLC boosted its holdings in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after acquiring an additional 138 shares in the last quarter. Quarry LP grew its position in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after acquiring an additional 114 shares during the last quarter. Finally, Carolina Wealth Advisors LLC acquired a new position in Clorox in the 3rd quarter worth about $48,000. Institutional investors own 78.53% of the company's stock.

Clorox Stock Down 1.1 %

Clorox stock traded down $1.71 on Friday, hitting $159.12. 948,374 shares of the stock traded hands, compared to its average volume of 992,704. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The business's fifty day simple moving average is $163.83 and its 200 day simple moving average is $157.13. The firm has a market cap of $19.70 billion, a P/E ratio of 55.44, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company's quarterly revenue was up 27.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 earnings per share. As a group, sell-side analysts forecast that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.07%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's payout ratio is presently 170.04%.

Analyst Ratings Changes

CLX has been the topic of several research reports. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and raised their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Wells Fargo & Company raised shares of Clorox from an "underweight" rating to an "equal weight" rating and boosted their price objective for the stock from $155.00 to $157.00 in a research note on Tuesday, January 7th. Evercore ISI lowered their target price on Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday, October 14th. Finally, Barclays reduced their price target on Clorox from $139.00 to $130.00 and set an "underweight" rating on the stock in a research report on Friday, January 17th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.